OR
Orgenesis Inc.
ORGS · OTC
$0.59 +0.00% (+$0.00)
1M +0.00%
Market Cap $5.78M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 10.91x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 58.93%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 1,080.19%
Net margin 10,445.50%
FCF margin 3,194.91%
Quality
1 /100
Poor ROIC 3,180.09%
ROA 380.44%
Asset turnover 0.04x
Debt
0 /100
High Current ratio 0.25x
Int. coverage -28.74x
Debt/Equity N/A
Stability
1 /100
Unstable Beta 3.14x
Rev. volatility 243.34%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ORGS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Vered Caplan
Employees
77
Headquarters
Germantown
Nadcházející události
11 LIS
Earnings
Upcoming earnings report